Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tallal Younis
Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
EXercise to Prevent AnthrCycline-based Cardio-Toxicity (EXACT) in Individuals With Breast or Hematological Cancers: A Feasibility Study Protocol
Pilot and Feasibility Studies
Medicine
Related publications
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues
Korean Journal of Clinical Oncology
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab With Taxane for Human Epidermal Growth Factor Receptor 2–positive Advanced Breast Cancer: Final Results From MARIANNE
Cancer
Cancer Research
Oncology
Patients’ Preferences for Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Treatments in Japan
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Is Associated With Indigenous American Ancestry in Latin American Women
Cancer Research
Cancer Research
Oncology
FEN1 Knockdown Improves Trastuzumab Sensitivity in Human Epidermal Growth Factor 2‑positive Breast Cancer Cells
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Meta-Analysis
Scientific Reports
Multidisciplinary
Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
Clinical Medicine Insights: Oncology
Oncology
